Back to Search Start Over

[Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].

Authors :
Stübiger N
Deuter C
Doycheva D
Source :
Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2020 May; Vol. 237 (5), pp. 591-598. Date of Electronic Publication: 2020 May 20.
Publication Year :
2020

Abstract

Behçet's syndrome (BS) is an inflammatory systemic disease associated with multiple organ manifestations. Major symptoms include oral and genital ulcerations, skin lesions and uveitis. Diagnosis of Behçet's syndrome is based on clinical findings. A typical for ocular Behçet's syndrome is recurrent non-granulomatous panuveitis with occlusive retinal vasculitis. Treatment used to be based only on the use of systemic corticosteroids and conventional immunosuppressives, but most often this treatment did not appear to be sufficient. In consequence, prognosis of ocular BS was very poor over a long period of time - especially if occlusive retinal vasculitis was present. In recent years, the introduction of biologicals has revolutionised the therapeutic regime and consecutively visual prognosis of ocular Behçet's syndrome has dramatically improved.<br />Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.<br /> (Georg Thieme Verlag KG Stuttgart · New York.)

Details

Language :
German
ISSN :
1439-3999
Volume :
237
Issue :
5
Database :
MEDLINE
Journal :
Klinische Monatsblatter fur Augenheilkunde
Publication Type :
Academic Journal
Accession number :
32434242
Full Text :
https://doi.org/10.1055/a-1140-3295